Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Shapiro

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|April 17, 2019
<i>In Vitro</i> Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014-2015Ian Morrissey, Sophie Magnet, Stephen Hawser, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporinTatiana Bogdanovich, Lois M Ednie, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Sigmoid <i>E</i><sub>max</sub> Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with CefepimePhilipp Knechtle, Stuart Shapiro, Ian Morrissey, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesisUte Galm, Stefanie Heller, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141Johan W Mouton, Anne Schmitt-Hoffmann, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureusLi-Yan Yin, Jason H Calhoun, Jacob K Thomas, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalisTatiana Bogdanovich, Catherine Clark, Lois Ednie, et al.
Vaccine|February 21, 2015
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, et al.
Journal of Clinical Microbiology|June 7, 2019
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor EnmetazobactamAdam Belley, Michael D Huband, Kelley A Fedler, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2009
In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugsPatrick Caspers, Luc Bury, Bérangère Gaucher, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|April 17, 2019
<i>In Vitro</i> Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014-2015Ian Morrissey, Sophie Magnet, Stephen Hawser, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporinTatiana Bogdanovich, Lois M Ednie, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Sigmoid <i>E</i><sub>max</sub> Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with CefepimePhilipp Knechtle, Stuart Shapiro, Ian Morrissey, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesisUte Galm, Stefanie Heller, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141Johan W Mouton, Anne Schmitt-Hoffmann, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureusLi-Yan Yin, Jason H Calhoun, Jacob K Thomas, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalisTatiana Bogdanovich, Catherine Clark, Lois Ednie, et al.
Vaccine|February 21, 2015
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, et al.
Journal of Clinical Microbiology|June 7, 2019
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor EnmetazobactamAdam Belley, Michael D Huband, Kelley A Fedler, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2009
In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugsPatrick Caspers, Luc Bury, Bérangère Gaucher, et al.
Pageof 3